Glytec and Parkview Health Expand Diabetes and Glycemic Management Partnership Across Indiana and Ohio

Renewal of 10 facilities, Emergency Department implementation, and two new hospital expansions position Parkview for CMS readiness

BOSTON, Oct. 9, 2025 /PRNewswire/ -- Glytec, the leading provider of AI-powered diabetes and glycemic management for hospitals and health systems, today announced an expanded partnership with Parkview Health, a not-for-profit health system serving northeast Indiana and northwest Ohio. The expansion renews 10 facilities, launches an Emergency Department implementation, and extends to two new hospitals.

This expansion supports Parkview Health's commitment to improving patient safety, clinical outcomes, clinician workflows, and readiness for the upcoming CMS electronic clinical quality measures (eCQMs) for severe hypoglycemia and hyperglycemia, effective January 1, 2026.

Renewals, Expansion, and ED Launch Strengthen Quality of Care

Parkview Health first partnered with Glytec to implement Glytec's FDA-cleared, EHR-integrated Glucommander® insulin titration software, a core component of the enterprise platform used by more than 400 hospitals to support diabetes and glycemic management across the continuum of care from the hospital to the home.

Meeting CMS Quality Mandates with Proven Technology

With CMS requiring reporting of eCQMs for inpatient glycemic control, hospitals face mounting pressure to improve care. Glytec's platform, integrated with Parkview's EHR, equips providers, IT teams, and executives with:

• Real-time clinical decision support for IV and subcutaneous insulin dosing
  
  
• Automated alerts for glucose excursions and proactive clinician workflows
  
  
• Advanced analytics to track patient-days in range, time to target, avoided adverse events and costs, financial outcomes and ROI, and CMS eCQM readiness

"Our work with Parkview Health underscores our joint mission to drive safe, standardized, and measurable improvements in inpatient glycemic management and outcomes," said Patrick Cua, CEO of Glytec. "This expanded collaboration enables Parkview to scale the leading diabetes and glycemic software solution across its enterprise and position it for CMS compliance and long-term population health success."

Driving Results Through Technology and Analytics

Glytec's platform, used by more than 400 hospitals and supported by over 100 clinical publications and over 100 patents, has demonstrated measurable results, including:

• Reduction in severe hypoglycemia events by up to 99.8%
  
  
• Shorter length of stay, fewer readmissions, and reduced testing costs
  
  
• 6 to 8x average return on investment

Parkview Health will leverage Glytec's turnkey platform to monitor real-time quality indicators and track outcomes across existing and newly launched sites. The platform also provides tools for clinical leaders and quality teams to benchmark performance, conduct automated audits, and streamline reporting tied to CMS requirements.

About Glytec

Glytec's industry-leading, AI-driven technology platform, trusted by over 400 hospitals, empowers collaborative diabetes management and insulin dosing, improving patient outcomes, reducing hospital length of stay and readmissions, and optimizing clinical workflows. Its flagship solution, Glucommander®—the first-ever FDA-cleared cloud-based insulin management software—integrates seamlessly with EHRs, providing advanced clinical decision support, workflow alerts, patient monitoring, and comprehensive analytics. Supported by industry awards and over 100 patents and 100 peer-reviewed publications, Glytec is dedicated to improving care from the hospital to the home for consumers, providers, and payors. For more information, visit www.glytec.com or follow Glytec on LinkedIn.

About Parkview Health

Parkview Health is a not-for-profit, community-owned health system serving northeast Indiana and northwest Ohio. With more than 16,000 employees and 15 hospitals—including Parkview Regional Medical Center, Parkview Bryan, and Parkview Montpelier—the system delivers high-quality care across a wide range of specialties, including heart, orthopedics, neuroscience, trauma, cancer, behavioral health, and women's and children's services. Parkview Physicians Group supports nearly 1,200 providers in more than 40 specialties across 300 locations. Founded on a mission to improve health and inspire well-being, Parkview Health reinvests every dollar back into the community to advance care access, technology, and innovation for all patients—regardless of ability to pay. For more information, visit www.parkview.com.

Media Contact:
Glytec Public Relations
GlytecPR@glytec.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/glytec-and-parkview-health-expand-diabetes-and-glycemic-management-partnership-across-indiana-and-ohio-302579793.html

SOURCE Glytec, LLC